Proteasome inhibitor Epoxomicin, Purity ≥98%

Synonym: 134381-21-8; Proteasome inhibitor; BU-4061T

MDL: MFCD03791061
CAS Number: 134381-21-8
Compound CID: 11226684

Product Size

1 mg; 2 mg; 5 mg; 10 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Epoxomicin, soluble in DMSO and ethanol and insoluble in water, interferes with the proteasome’s ability to degrade proteins, thereby disrupting cellular processes in cancer cells, particularly multiple myeloma. It targets 20S proteasome.

Molecular Weight

554.7

Molecular Formula

C₂₈H₅₀N₄O₇

Targets

20S proteasome

Form

Lyophilized powder

Purity

≥98%

Solubility

DMSO: 98 mg/mL (176.66 mM); Water: Insoluble; Ethanol: 98 mg/mL (176.66 mM)

Identity

Confirmed by NMR/HPLC/MS.

Applications

Epoxomicin is applied in studies examining proteasome inhibition in cancer cell apoptosis research.